Drug – bio-affecting and body treating compositions – Immune response affecting drug
Patent
1992-06-24
1993-10-12
Dess, Jose G.
Drug, bio-affecting and body treating compositions
Immune response affecting drug
514286, 435119, 546 63, A61K 3500
Patent
active
052526127
ABSTRACT:
Described is a new immunosuppressant, L-683,756, a bisdemethylated, ring rearranged derivative of L-683,590, produced under fermentation conditions utilizing the microorganism, Actinoplanacete sp. (Merck Culture Collection MA 6559) ATCC No. 53771. The macrolide immunosuppressant is useful in preventing human host rejection of foreign organ transplants, e.g. bone marrow and heart transplants.
REFERENCES:
New York Times (Oct. 18, 1989), pA1, by L. K. Altman.
Transplantation, vol. 32, No. 5, p. 350, by P. E. Morris.
Ann. Rev. Immunol., vol. 3, p. 415, by E. M. Sherach (1985).
J. Antiobiotics, (Nov. 1988) vol. 16 p. 1600, by Hatanaka, et al.
J. Immunology, vol. 144, pp. 251-258, No. 1, (Jan. 1, 1990).
Arison Byron H.
Chen Shieh-Shung T.
Inamine Edward S.
Wicker Linda S.
Carr D. B.
Dess Jose G.
Merck & Co. , Inc.
Mitri Salvatore C.
North Robert J.
LandOfFree
Microbial immunosoppressant agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Microbial immunosoppressant agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Microbial immunosoppressant agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1904895